Is XBiotech Inc (XBIT) overvalued? · $83.8M cap
XBiotech Inc (XBIT) is a biotechnology company listed on US.
This page asks whether XBiotech Inc (XBIT) looks expensive on cached numbers — not a short thesis.
No cached income statement for XBIT, so there is no earnings base to call rich or cheap.
XBIT currently screens at market cap $83.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next XBIT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the XBIT stock page for the full model, not this heading.
Not investment advice.